Charles Theuer - 18 Nov 2021 Form 4 Insider Report for Tracon Pharmaceuticals, Inc.

Role
President and CEO, Director
Signature
/s/ Scott B. Brown, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
18 Nov 2021
Net transactions value
+$11,831
Form type
4
Filing time
22 Nov 2021, 15:21:05 UTC
Previous filing
09 Nov 2021
Next filing
01 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TCON Common Stock Purchase $1,961 +681 +0.32% $2.88* 215,818 18 Nov 2021 Direct
transaction TCON Common Stock Purchase $9,870 +3,500 +1.6% $2.82* 219,318 19 Nov 2021 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.